# Syros Pharmaceuticals, Inc. (SYRS)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/SYRS/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2024 | $ 0 | $ -35.14M | $ -85.61M | $ 60.23M | $ -11.12M |
| 2023 | $ 10.74M | $ -168.36M | $ -118.92M | $ 62.08M | $ 16.66M |
| 2022 | $ 11.36M | $ -58.43M | $ -138.86M | $ 63.57M | $ 127.74M |
| 2021 | $ 27.92M | $ -102.89M | $ -119.80M | $ 65.19M | $ 85.22M |
| 2020 | $ 19.23M | $ -107.06M | $ -77.33M | $ 66.21M | $ 90.55M |
| 2019 | $ 2.56M | $ -97.37M | $ -94.08M | $ 25.92M | $ 79.18M |
| 2018 | $ 2.71M | $ -82.25M | $ -55.07M | $ 31.0K | $ 78.59M |
| 2017 | $ 1.48M | $ -72.76M | $ -61.36M | $ 53.0K | $ 65.32M |
| 2016 | $ 436.1K | $ -65.69M | $ -58.97M | $ 221.0K | $ 80.60M |
| 2015 | $ 445.1K | $ -41.87M | $ -33.99M | $ 339.0K | $ 34.05M |
| 2014 | $ 0 | $ -6.82M | $ -4.97M | $ 0 | $ 60.24M |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | -5.41 |
| Liabilities / Eq | -8.64 |
| Current Ratio | 2.25 |

## Other views

- [Metrics](https://sponda.capital/en/SYRS.md)
- [Charts](https://sponda.capital/en/SYRS/charts.md)
- [Compare](https://sponda.capital/en/SYRS/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-30.